Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
TSE/TYO:4570
Immuno-Biological Laboratories Co., Ltd. (4570) Stock Price & Analysis
0 Followers
4570 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥408.00 - ¥961.00
Previous Close¥535
Volume131.50K
Average Volume (3M)78.31K
Market Cap
¥4.98B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)26.7
Beta0.49
Next Earnings
Aug 08, 2024EPS EstimateN/A
Last Dividend Ex-Date
Mar 27, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)20.05
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume78,315
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4570 FAQ
What was Immuno-Biological Laboratories Co., Ltd.’s price range in the past 12 months?
Immuno-Biological Laboratories Co., Ltd. lowest stock price was ¥408.00 and its highest was ¥961.00 in the past 12 months.
What is Immuno-Biological Laboratories Co., Ltd.’s market cap?
Currently, no data Available
When is Immuno-Biological Laboratories Co., Ltd.’s upcoming earnings report date?
Immuno-Biological Laboratories Co., Ltd.’s upcoming earnings report date is Aug 08, 2024 which is in 20 days.
How were Immuno-Biological Laboratories Co., Ltd.’s earnings last quarter?
Immuno-Biological Laboratories Co., Ltd. released its earnings results on May 14, 2024. The company reported ¥17.835 earnings per share for the quarter, beating the consensus estimate of N/A by ¥17.835.
Is Immuno-Biological Laboratories Co., Ltd. overvalued?
According to Wall Street analysts Immuno-Biological Laboratories Co., Ltd.’s price is currently Overvalued.
Does Immuno-Biological Laboratories Co., Ltd. pay dividends?
Immuno-Biological Laboratories Co., Ltd. pays a Notavailable dividend of ¥5 which represents an annual dividend yield of N/A. See more information on Immuno-Biological Laboratories Co., Ltd. dividends here
What is Immuno-Biological Laboratories Co., Ltd.’s EPS estimate?
Immuno-Biological Laboratories Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immuno-Biological Laboratories Co., Ltd. have?
Immuno-Biological Laboratories Co., Ltd. has 9,314,590 shares outstanding.
What happened to Immuno-Biological Laboratories Co., Ltd.’s price movement after its last earnings report?
Immuno-Biological Laboratories Co., Ltd. reported an EPS of ¥17.835 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.949%.
Which hedge fund is a major shareholder of Immuno-Biological Laboratories Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4570
---
Immuno-Biological Laboratories Co., Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technical Analysis
Symbio Pharmaceuticals Limited
―
Oncolys BioPharma, Inc.
―
RaQualia Pharma Inc.
―
---